Peay HL, Fischer R, Mange B, Paquin RS, Smith EC, Sadosky A, Russo L, Ricotti V, Rensch C, Morris C, Martin AS, Ganot A, Beaverson K, Mansfield C. Patients' and caregivers' maximum acceptable risk of death for non-curative gene therapy to treat Duchenne muscular dystrophy. Mol Genet Genomic Med. 2021 May;9(5):e1664. doi: 10.1002/mgg3.1664
Kim ES, Tkatch R, Martin D, MacLeod S, Sandy L, Yeh C. Resilient aging: psychological well-being and social well-being as targets for the promotion of healthy aging. Gerontol Geriatr Med. 2021 Mar 23;7:233372142. doi: 10.1177/23337214211002951
Sebastian J, Cai L, Williamson D, Foushee B, Kam-Morgan L, Eisenberg MT. Identification and characterization of two novel sequence variants in the Thrombopoietin Receptor (MPL) gene using data from 8700 JAK-2 V617F negative patients. Poster presented at the 2016 Association for Molecular Pathology (AMP) Annual Meeting; November 10, 2016. Charlotte, NC. [abstract] J Mol Diagn. 2016 Nov; 18(6):955. doi: 10.1016/S1525-1578(16)30176-3
Tkatch R, Musich S, MacLeod S, Alsgaard K, Hawkins K, Yeh CS. Population health management for older adults: review of interventions for promoting successful aging across the health continuum. Gerontol Geriatr Med. 2016 Sep 18;2:233372141. doi: 10.1177/2333721416667877
Musich S, MacLeod S, Bhattarai GR, Wang SS, Hawkins K, Bottone, Jr. FG, Yeh CS. The impact of obesity on health utilization and expenditures in a medicare supplement. Gerontol Geriatr Med. 2016 Jan 19;2:233372141. doi: 10.1177/2333721415622004
Offen W, Chuang-Stein C, Dmitrienko A, Copley-Merriman K. Multiple co-primary endpoints: medical and statistical solutions: a report from the multiple endpoints expert team of the PhRMA. Drug Inf J. 2007;4:31-46.
Backhouse ME, Gnanasakthy A, Schulman KA, Akehurst R, Glick H. The development of standard economic datasets for use in the economic evaluation of medicines. Drug Inf J. 2000;34(4):1273-91.
Ciociola AA, Webb DD, McSorley DJ. The continued use of placebo-controlled clinical trials in the study of peptic ulcer disease: a sponsor perspective. Drug Inf J. 1996 Apr;30(2):433-9.
Doward LC. Developing a measure of quality of life for patients with recurrent genital herpes. Drug Inf J. 1994 Jan 1;28(1):19-25.
Koch GG, Amara LA, Forster JK, McSorley DJ, Peace KE. Statistical issues in the design and analysis of ulcer healing and recurrence studies. Drug Inf J. 1993 Jul;27(3):805-24.